{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:57:05Z","timestamp":1777431425133,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00246-018-1889-5","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T04:04:50Z","timestamp":1526529890000},"page":"1242-1248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy"],"prefix":"10.1007","volume":"39","author":[{"given":"Defne A.","family":"Magnetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JaHyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Wearden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"issue":"10","key":"1889_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","volume":"12","author":"M Eagle","year":"2002","unstructured":"Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord NMD 12(10):926\u2013929","journal-title":"Neuromuscul Disord NMD"},{"issue":"2","key":"1889_CR2","first-page":"121","volume":"31","author":"L Passamano","year":"2012","unstructured":"Passamano L, Taglia A, Palladino A, Viggiano E, D\u2019Ambrosio P, Scutifero M et al (2012) Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol 31(2):121\u2013125","journal-title":"Acta Myol"},{"issue":"3","key":"1889_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271\u2013277","journal-title":"Int J Cardiol"},{"issue":"21","key":"1889_CR4","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533\u20132546","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1889_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.109.858076","volume":"122","author":"D Mancini","year":"2010","unstructured":"Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122(2):173\u2013183","journal-title":"Circulation"},{"issue":"12","key":"1889_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","volume":"34","author":"JK Kirklin","year":"2015","unstructured":"Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transpl 34(12):1495\u20131504","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"1889_CR7","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ijcard.2012.04.009","volume":"161","author":"A Amodeo","year":"2012","unstructured":"Amodeo A, Adorisio R (2012) Left ventricular assist device in Duchenne cardiomyopathy: can we change the natural history of cardiac disease? Int J Cardiol 161(3):e43","journal-title":"Int J Cardiol"},{"issue":"2","key":"1889_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MAT.0000000000000050","volume":"60","author":"TD Ryan","year":"2014","unstructured":"Ryan TD, Jefferies JL, Sawnani H, Wong BL, Gardner A, Del Corral M et al (2014) Implantation of the HeartMate II and HeartWare left ventricular assist devices in patients with duchenne muscular dystrophy: lessons learned from the first applications. ASAIO 60(2):246\u2013248","journal-title":"ASAIO"},{"issue":"18","key":"1889_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","volume":"131","author":"EM McNally","year":"2015","unstructured":"McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D et al (2015) Contemporary cardiac issues in duchenne muscular dystrophy. Circulation 131(18):1590\u20131598","journal-title":"Circulation"},{"issue":"4","key":"1889_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"FA Sonnenberg","year":"1993","unstructured":"Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Mak 13(4):322\u2013338","journal-title":"Med Decis Mak"},{"issue":"6907","key":"1889_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/bmj.307.6907.793","volume":"307","author":"R Robinson","year":"1993","unstructured":"Robinson R (1993) Cost-effectiveness analysis. BMJ 307(6907):793\u2013795","journal-title":"BMJ"},{"issue":"3","key":"1889_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/0272989X0002000310","volume":"20","author":"RA Hirth","year":"2000","unstructured":"Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG (2000) Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Mak 20(3):332\u2013342","journal-title":"Med Decis Mak"},{"key":"1889_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1749-8090-7-76","volume":"7","author":"V Mishra","year":"2012","unstructured":"Mishra V, Fiane AE, Geiran O, S\u00f8rensen G, Khushi I, Hagen TP (2012) Hospital costs fell as numbers of LVADs were increasing: experiences from Oslo University Hospital. J Cardiothorac Surg 7:76","journal-title":"J Cardiothorac Surg"},{"issue":"5","key":"1889_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.healun.2011.10.017","volume":"31","author":"SG Moreno","year":"2012","unstructured":"Moreno SG, Novielli N, Cooper NJ (2012) Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transpl 31(5):450\u2013458","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"1889_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S0266462313000238","volume":"29","author":"M Neyt","year":"2013","unstructured":"Neyt M, Van den Bruel A, Smit Y, De Jonge N, Erasmus M, Van Dijk D et al (2013) Cost-effectiveness of continuous-flow left ventricular assist devices. Int J Technol Assess Health Care 29(3):254\u2013260","journal-title":"Int J Technol Assess Health Care"},{"issue":"11","key":"1889_CR16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.healun.2006.09.011","volume":"25","author":"LD Sharples","year":"2006","unstructured":"Sharples LD, Dyer M, Cafferty F, Demiris N, Freeman C, Banner NR et al (2006) Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transpl 25(11):1336\u20131343","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"1889_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCHEARTFAILURE.111.962951","volume":"5","author":"JG Rogers","year":"2012","unstructured":"Rogers JG, Bostic RR, Tong KB, Adamson R, Russo M, Slaughter MS (2012) Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail 5(1):10\u201316","journal-title":"Circ Heart Fail"},{"issue":"3","key":"1889_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.athoracsur.2015.03.010","volume":"100","author":"SA Akhter","year":"2015","unstructured":"Akhter SA, Badami A, Murray M, Kohmoto T, Lozonschi L, Osaki S et al (2015) Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg 100(3):884\u2013889","journal-title":"Ann Thorac Surg"},{"key":"1889_CR19","first-page":"163","volume":"6","author":"S Chen","year":"2015","unstructured":"Chen S, Lin A, Liu E, Gowan M, May LJ, Doan LN et al (2015) Outpatient outcomes of pediatric patients with left ventricular assist devices. ASAIO J 6:163\u2013168","journal-title":"ASAIO J"},{"issue":"8","key":"1889_CR20","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/0883073808314962","volume":"23","author":"L Ouyang","year":"2008","unstructured":"Ouyang L, Grosse SD, Kenneson A (2008) Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population. J Child Neurol 23(8):883\u2013888","journal-title":"J Child Neurol"},{"issue":"8","key":"1889_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cardfail.2008.06.005","volume":"14","author":"MJ Russo","year":"2008","unstructured":"Russo MJ, Gelijns AC, Stevenson LW, Sampat B, Aaronson KD, Renlund DG et al (2008) The cost of medical management in advanced heart failure during the final two years of life. J Card Fail 14(8):651\u2013658","journal-title":"J Card Fail"},{"key":"1889_CR22","unstructured":"Cost To Charge Ratio High Values For FY (2016) [Internet]. \n                    https:\/\/www.dol.gov\/owcp\/regs\/feeschedule\/fee\/fee15\/CCR_Table_FY_2016.htm\n                    \n                  . Accessed 5 Jan 2017"},{"key":"1889_CR23","unstructured":"CPI Inflation Calculator [Internet]. \n                    https:\/\/www.bls.gov\/data\/inflation_calculator.htm\n                    \n                  . Accessed 5 Jan 2017"},{"issue":"20","key":"1889_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","volume":"345","author":"EA Rose","year":"2001","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435\u20131443","journal-title":"N Engl J Med"},{"issue":"1","key":"1889_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1524-4733.2008.00425.x","volume":"12","author":"A G\u00f6hler","year":"2009","unstructured":"G\u00f6hler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS et al (2009) Utility estimates for decision-analytic modeling in chronic heart failure\u2013health states based on New York Heart Association classes and number of rehospitalizations. Value Health 12(1):185\u2013187","journal-title":"Value Health"},{"issue":"6","key":"1889_CR26","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1542\/peds.2012-0858","volume":"130","author":"K Uzark","year":"2012","unstructured":"Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K et al (2012) Health-related quality of life in children and adolescents with duchenne muscular dystrophy. Pediatrics 130(6):e1559\u2013e1566","journal-title":"Pediatrics"},{"issue":"1","key":"1889_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.amjcard.2014.04.008","volume":"114","author":"DG Jakovljevic","year":"2014","unstructured":"Jakovljevic DG, McDiarmid A, Hallsworth K, Seferovic PM, Ninkovic VM, Parry G et al (2014) Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life. Am J Cardiol 114(1):88\u201393","journal-title":"Am J Cardiol"},{"issue":"23","key":"1889_CR28","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","volume":"361","author":"MS Slaughter","year":"2009","unstructured":"Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241\u20132251","journal-title":"N Engl J Med"},{"issue":"5","key":"1889_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0272989X12458348","volume":"32","author":"AH Briggs","year":"2012","unstructured":"Briggs AH, Weinstein MC, Fenwick EAL, Karnon J, Sculpher MJ, Paltiel AD et al (2012) Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6. Med Decis Mak 32(5):722\u2013732","journal-title":"Med Decis Mak"},{"issue":"6","key":"1889_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","volume":"33","author":"JK Kirklin","year":"2014","unstructured":"Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al (2014) Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transpl 33(6):555\u2013564","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"1889_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S1053-2498(03)00073-1","volume":"22","author":"MC Deng","year":"2003","unstructured":"Deng MC, Young JB, Stevenson LW, Oz MC, Rose EA, Hunt SA et al (2003) Destination mechanical circulatory support: proposal for clinical standards. J Heart Lung Transpl 22(4):365\u2013369","journal-title":"J Heart Lung Transpl"},{"key":"1889_CR32","unstructured":"Phurrough S, Salive M, Baldwin J, Ulrich M (2007) Decision memo for ventricular assist devices as destination therapy (CAG-00119R). Center for medicare and medicaid services. \n                    https:\/\/www.cms.gov\/medicare-coverage-database\/details\/nca-decision-memo.aspx?NCAId=187&ver=16&NcaName=Ventricular+Assist+Devices+as+Destination+Therapy\n                    \n                  . Accessed 25 Jun 2016"},{"key":"1889_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1750-1172-9-75","volume":"9","author":"TA Kanters","year":"2014","unstructured":"Kanters TA, Hoogenboom-Plug I, Rutten-Van M\u00f6lken MPMH, Redekop WK, van der Ploeg AT, Hakkaart L (2014) Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease. Orphanet J Rare Dis 9:75","journal-title":"Orphanet J Rare Dis"},{"key":"1889_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-9-51","volume":"9","author":"L Dussen van","year":"2014","unstructured":"van Dussen L, Biegstraaten M, Hollak CEM, Dijkgraaf MGW (2014) Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease. Orphanet J Rare Dis 9:51","journal-title":"Orphanet J Rare Dis"},{"issue":"18","key":"1889_CR35","first-page":"1","volume":"18","author":"P Whiting","year":"2014","unstructured":"Whiting P, Al M, Burgers L, Westwood M, Ryder S, Hoogendoorn M et al (2014) Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technol Assess Winch Engl 18(18):1\u2013106","journal-title":"Health Technol Assess Winch Engl"},{"issue":"2","key":"1889_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1586\/14737167.8.2.165","volume":"8","author":"SD Grosse","year":"2008","unstructured":"Grosse SD (2008) Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 8(2):165\u2013178","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"1889_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1750-1172-7-74","volume":"7","author":"W Hughes-Wilson","year":"2012","unstructured":"Hughes-Wilson W, Palma A, Schuurman A, Simoens S (2012) Paying for the orphan drug system: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments? Orphanet J Rare Dis 7(1):74","journal-title":"Orphanet J Rare Dis"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1889-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1889-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1889-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T23:16:11Z","timestamp":1558048571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1889-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1889-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"28 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Defne Magnetta, JaHyun Kang, Peter Wearden, Kenneth Smith, and Brian Feingold declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}